Bill Carson is a Pioneer at Artis Ventures. Bill retired from Otsuka Pharmaceuticals at the end of 2019 after serving as CEO for 10 years and helping develop one of the top grossing pharmaceutical drugs, Abilify.


As a Pioneer, Bill brings commercial pharma and drug development expertise, and currently sits on the advisory board at Artis Ventures portfolio company, Excision BioTherapeutics.

William Carson, MD